Back to Authors

Giannotti, Maxine

A5021209153 | I1285764155

Mayo Clinic

Merck & Co., Inc., Rahway, NJ, USA (United States)

Citations 2

Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001.

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 9050-9050

10.1200/jco.2015.33.15_suppl.9050

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma

JAMA | April 19, 2016 | Volume: 315 | Issue: 15 | Pages: 1600

10.1001/jama.2016.4059 | PMID 27092830